Hifibio Therapeutics
Clinical trials sponsored by Hifibio Therapeutics, explained in plain language.
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control OngoingThis is an early-stage study to find a safe dose of a new immunotherapy drug called HFB200301. It is being tested alone and in combination with an existing drug (tislelizumab) in adults with advanced solid tumors who have already tried other treatments. The main goal is to see ho…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New cancer drug combo enters first human tests
Disease control OngoingThis is an early-stage study to find a safe dose of a new immunotherapy drug called HFB200603. It will be tested alone and in combination with an existing drug, tislelizumab, in 83 adults with advanced solid tumors like lung, kidney, or skin cancer. The main goal is to check for …
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC